Bausch Health Valuation
| BHC Stock | USD 5.76 0.02 0.35% |
At this time, the firm appears to be undervalued. Bausch Health Companies shows a prevailing Real Value of $6.25 per share. The current price of the firm is $5.76. Our model approximates the value of Bausch Health Companies from analyzing the firm fundamentals such as Return On Equity of 0.56, current valuation of 21.8 B, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bausch Health's valuation include:
Price Book 18.7773 | Enterprise Value | Enterprise Value Ebitda 6.6282 | Price Sales 0.2123 | Forward PE 1.2958 |
Undervalued
Today
Please note that Bausch Health's price fluctuation is slightly risky at this time. Calculation of the real value of Bausch Health Companies is based on 3 months time horizon. Increasing Bausch Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bausch Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bausch Stock. However, Bausch Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.76 | Real 6.25 | Target 7.43 | Hype 5.76 | Naive 5.01 |
The real value of Bausch Stock, also known as its intrinsic value, is the underlying worth of Bausch Health Companies Company, which is reflected in its stock price. It is based on Bausch Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bausch Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bausch Health Companies helps investors to forecast how Bausch stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bausch Health more accurately as focusing exclusively on Bausch Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bausch Health's intrinsic value based on its ongoing forecasts of Bausch Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bausch Health's closest peers. If more than one evaluation category is relevant for Bausch Health we suggest using both methods to arrive at a better estimate.
Bausch Health Cash |
|
Bausch Revenue by Product
Bausch Health Total Value Analysis
Bausch Health Companies is currently forecasted to have company total value of 21.8 B with market capitalization of 2.13 B, debt of 21.83 B, and cash on hands of 1.18 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Bausch Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.8 B | 2.13 B | 21.83 B | 1.18 B |
Bausch Health Investor Information
About 64.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.63. Bausch Health Companies last dividend was issued on the 10th of November 2010. The entity had 2:1 split on the 16th of October 2000. Bausch Health Companies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Bausch Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bausch Health has an asset utilization ratio of 36.29 percent. This indicates that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Bausch Health Companies is more efficient with each dollar of assets it utilizes for everyday operations.Bausch Health Profitability Analysis
Considering the key profitability indicators obtained from Bausch Health's historical financial statements, Bausch Health Companies may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Bausch Health's ability to earn profits and add value for shareholders.Net Loss | First Reported 1994-03-31 | Previous Quarter 148 M | Current Value 179 M | Quarterly Volatility 368.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.81 | 0.82 |
|
|
For Bausch Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bausch Health Companies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bausch Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bausch Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bausch Health over time as well as its relative position and ranking within its peers.
Bausch Health Earnings per Share Projection vs Actual
The next projected EPS of Bausch Health is estimated to be 1.049575 with future projections ranging from a low of 0.93 to a high of 1.17. Bausch Health's most recent 12-month trailing earnings per share (EPS TTM) is at 1.0. Please be aware that the consensus of earnings estimates for Bausch Health Companies is based on EPS before non-recurring items and includes expenses related to employee stock options.Bausch Health Earnings Estimation Breakdown
The calculation of Bausch Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bausch Health is estimated to be 1.049575 with the future projection ranging from a low of 0.93 to a high of 1.17. Please be aware that this consensus of annual earnings estimates for Bausch Health Companies is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.93 Lowest | Expected EPS | 1.17 Highest |
Bausch Health Earnings Projection Consensus
Suppose the current estimates of Bausch Health's value are higher than the current market price of the Bausch Health stock. In this case, investors may conclude that Bausch Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bausch Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 9 | 67.49% | 0.0 | 1.049575 | 1.0 |
Bausch Health Ownership Allocation
Bausch Health holds a total of 370.52 Million outstanding shares. Over half of Bausch Health's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bausch Health Profitability Analysis
The company reported the last year's revenue of 9.62 B. Reported Net Loss for the year was (72 M) with profit before taxes, overhead, and interest of 7.09 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bausch Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bausch Health and how it compares across the competition.
About Bausch Health Valuation
The stock valuation mechanism determines Bausch Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bausch Health. We calculate exposure to Bausch Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bausch Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.9 B | 8.3 B | |
| Pretax Profit Margin | 0.02 | 0.02 | |
| Operating Profit Margin | 0.16 | 0.18 | |
| Net Loss | (0.01) | (0.01) | |
| Gross Profit Margin | 0.82 | 0.81 |
Bausch Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 368 M | |
| Quarterly Earnings Growth Y O Y | 13.68 | |
| Forward Price Earnings | 1.2958 |
Bausch Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Bausch Health Companies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Bausch we look at many different elements of the entity such as Bausch's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bausch Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bausch Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bausch Health's worth.Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |